PDT Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.12M | Sell |
|
|||||
|
2025
Q1 | $5.84M | Buy |
|
|||||
|
2024
Q4 | $3.93M | Buy |
|
|||||
|
2024
Q3 | $3.97M | Buy |
|
|||||
|
2024
Q2 | $2.27M | Sell |
|
|||||
|
2024
Q1 | $1.93M | Buy |
|
|||||
|
2023
Q4 | $1.86M | Buy |
|
|||||
|
2023
Q3 | $1.92M | Buy |
|
|||||
|
2023
Q2 | $1.4M | Buy |
|
|||||
|
2023
Q1 | $921K | Buy |
|
|||||
|
2022
Q4 | $699K | Sell |
|
|||||
|
2022
Q3 | $808K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $412K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $718K | Hold |
|
|||||
|
2017
Q1 | $1.08M | Sell |
|
|||||
|
2016
Q4 | $828K | Sell |
|
|||||
|
2016
Q3 | $714K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.12M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $689K | Sell |
|
|||||
|
2014
Q2 | $1.28M | Buy |
|
|||||
|
2014
Q1 | $423K | Sell |
|
|||||
|
2013
Q4 | $692K | Buy |
|
|||||
|
2013
Q3 | $248K | Buy |
|